Formulation delivery system

Abstract

A system and method of humanely dosing a human or animal with a formulation at a distance. A system capable of dosing a recipient with a formulation having a mass between 10 and 500 grains propelled at low-to-medium ballistic velocities (300 to 800 feet per second) and with medium-to-long range ballistic accuracy (10 to over 100 yards) without causing serious physical harm to, nor the death of, the recipient.

What is claimed is: 
     
         1 . A projectile injection system for dosing a human or animal recipient from a distance, the system comprising:
 a housing having a longitudinal axis, a distal end, and a proximal end, wherein said housing has at least one cavity storing a hypodermic formulation and at least one outlet port through which the hypodermic formulation exits said housing; and   an injector head having at least one inlet port fluidly connected to the at least one outlet port of the housing, and at least one distal hypodermic needle extending distally from the injector head, the injector head mounted to the distal end of the housing via a rotatable hub,   wherein upon contact with the recipient, the at least one distal hypodermic needle penetrates the recipient and the hypodermic formulation exits the at least one cavity and passes through the at least one outlet port of the housing into the at least one inlet port of the injector head and through the at least one distal hypodermic needle, so that the recipient is dosed with the hypodermic formulation without causing serious injury to or the death of the recipient.   
     
     
         2 . The system of  claim 1 , wherein the hypodermic formulation is a cannabinoid formulation. 
     
     
         3 . The system of  claim 2 , wherein the cannabinoid formulation includes less than 9200 mg of tetrahydrocannabinol per kg of body weight of the recipient, such that the dose administered to the recipient is a non-lethal dose. 
     
     
         4 . The system of  claim 1 , wherein said projectile injection system is propelled by and from the group consisting of lethal ballistic weapons such as single-shot, semi-automatic, or fully-automatic revolvers, pistols, shotguns, scatterguns, rifles, grenade launchers, rocket launchers, mortars, light artillery, heavy artillery, missile launchers, and combinations thereof 
     
     
         5 . The system of  claim 1 , wherein said projectile injection system is configured to undergo spiraling ballistic flight. 
     
     
         6 . The system of  claim 5 , wherein the injector head has a longitudinal axis that is common with the longitudinal axis of the housing, and wherein upon contact with the recipient, the at least one hypodermic needle cooperatively with the direction of rotation penetrates the dermis of the recipient to a depth facilitative of and suitable for subdermal bolus injection of the formulation, wherein the at least one hypodermic needle constructively stops both distal and rotational movement along the common longitudinal axis when the injector head impacts the recipient. 
     
     
         7 . The system of  claim 6 , wherein the rotatable hub allows said housing to continue rotation along the common longitudinal axis, thus dissipating the remaining kinetic energy after the injector head has constructively stopped rotation. 
     
     
         8 . The system of  claim 1 , wherein the housing further includes a plunger and a housing vent, wherein the housing vent allows for housing pressure equalization when and as the plunger displaces resulting in the injection of the formulation into the recipient. 
     
     
         9 . The system of  claim 1 , wherein the injection system comprises a turbine or worm gear in communication with the rotatable hub, wherein when the housing continues rotation as the injector head remains constructively stationary, the turbine or worm gear forces the formulation through the at least one outlet port resulting in the injection of the formulation into the recipient. 
     
     
         10 . The system of  claim 1 , wherein the system is reusable. 
     
     
         11 . The system of  claim 1 , wherein the injector system utilizes inertial forces upon impact of the injector head with the recipient resulting in the injection of the formulation into the recipient. 
     
     
         12 . The system of  claim 8 , wherein the housing further includes a worm gear along the common longitudinal axis in communication with the plunger and in communication with the rotatable hub, whereby the continuing rotation of the housing along the common longitudinal axis in relation to the hypodermic injector head and after impact with the recipient causes the plunger to displace along the common longitudinal axis resulting in the injection of the formulation. 
     
     
         13 . The system of  claim 8 , wherein the housing further includes a gas under pressure, wherein when the gas is suddenly released, or comprises an explosive substance whereby when ignited expands, or comprises a spring under compression whereby when suddenly released, causes the plunger to displace resulting in the injection of the formulation. 
     
     
         14 . The system of  claim 1 , wherein the at least one hypodermic needle further includes a barb. 
     
     
         15 . The system of  claim 1 , wherein the at least one hypodermic needle is configured in an arc. 
     
     
         16 . The system of  claim 15 , wherein the at least one hypodermic needle is configured in one or more cycloidal, epicycloidal, hypocycloidal, or other spiral arc. 
     
     
         17 . The system of  claim 1 , wherein the injector head further comprises a cooperative strut corresponding to the at least one hypodermic needle and configured in such a manner as to facilitate dermal penetration of the recipient by the at least one hypodermic needle and to facilitate the injection of the formulation into the recipient. 
     
     
         18 . The system of  claim 1 , wherein the injector head comprises a plurality of hypodermic needles cooperatively corresponding to the at least one hypodermic needle and configured in such a manner as to facilitate dermal penetration of the recipient by the plurality of hypodermic needles and to facilitate injection of the formulation into the recipient. 
     
     
         19 . The system of  claim 1 , wherein the outer circumference of the projectile injection system changes during ballistic flight. 
     
     
         20 . The system of  claim 1 , wherein the outer circumference of the projectile injection system changes after impacting the recipient. 
     
     
         21 . The system of  claim 1 , wherein the projectile injection system emits a sound during ballistic flight or during rotation after the injector head impacts the recipient. 
     
     
         22 . The system of  claim 1 , wherein the rotatable hub further includes or operates as a clutch between the housing and the injector head. 
     
     
         23 . The system of  claim 1 , wherein the injector head further includes an airfoil. 
     
     
         24 . A propelled injection system for dosing a human or animal at a distance comprising:
 a housing including at least one cavity, at least one outlet port, a vent, a plunger, and a hypodermic cannabinoid formulation; and   an injector head mounted to the housing via a rotatable hub, the injector head including at least one inlet port and at least one hypodermic needle,   wherein when the injector head impacts a recipient, the at least one hypodermic needle penetrates the dermis of the recipient to a depth facilitative of and suitable for subdermal bolus injection due to the rotatable hub allowing the housing to continue rotation while the injector head stops rotation, wherein the remaining kinetic energy after the injector head has constructively stopped rotation is dissipated; and   whereby upon the injector head base impacting the recipient the vent allows for housing pressure equalization as the plunger displaces resulting in the dosing of the recipient with the formulation without causing serious injury to or the death of the recipient.   
     
     
         25 . A method for dosing a human or animal at a distance with a formulation, the method comprising the steps of:
 providing a propelled injection system including
 a housing including at least one outlet port and a hypodermic formulation, and 
 a hypodermic injector head including at least one inlet port and at least one hypodermic needle, 
 wherein the hypodermic injector head is mounted to the housing via a rotational hub; and 
   propelling the housing and the hypodermic injector in a spiraling ballistic trajectory to impact a recipient,   wherein upon or after the injector head impacts the recipient, the recipient is dosed with the formulation without causing serious injury to or the death of the recipient resulting from the injector head impacting the recipient or the injecting of the hypodermic formulation.   
     
     
         26 . The method of  claim 25 , wherein when the spiraling hypodermic injector head impacts the recipient, the at least one hypodermic needle cooperatively with the direction of rotation penetrates the derma of the recipient to a depth facilitative of and suitable for subdermal bolus injection without causing serious injury to or the death of the recipient due to the rotational hub allowing the housing to continue rotation and thus dissipating the remaining kinetic energy after the injector head has stopped rotation. 
     
     
         27 . The method of  claim 25  wherein the propelled injection system is propelled by and from the group consisting of lethal ballistic weapons such as single-shot, semi-automatic, or fully-automatic revolvers, pistols, shotguns, scatterguns, rifles, grenade launchers, rocket launchers, mortars, light artillery, heavy artillery, missile launchers, and combinations thereof. 
     
     
         28 . A system for humanely immobilizing a human or animal, the system comprising:
 a formulation including a cannabinoid which renders a recipient incapacitated after dosing; and   a delivery system used to dose the recipient with the formulation at a distance,   wherein upon dosage of the recipient, a tetrahydrocannabinol blood level is induced greater than one-to-fifty milligrams per milliliter of whole blood (1-50 mg/ml) and below a dosage which causes irreparable harm to or the death of the recipient, and   wherein upon dosage of the recipient, the recipient becomes immobilized.